Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rifaquat Musaffa Rahman, M.D.

Concepts (125)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms21202288052.410 Why?
Glioblastoma17202233462.060 Why?
Controlled Clinical Trials as Topic120211930.800 Why?
Lymphopenia120222790.790 Why?
Glioma3202233020.700 Why?
Cranial Irradiation220204410.680 Why?
Central Nervous System Neoplasms220228680.600 Why?
Research Design6202259020.580 Why?
Antineoplastic Agents, Alkylating120206450.560 Why?
Clinical Trials, Phase III as Topic120198140.550 Why?
Patient Care120216200.530 Why?
Angiogenesis Inhibitors5201720740.520 Why?
Neurology120217460.480 Why?
Meningioma1202112000.460 Why?
Radiation Injuries1202012240.450 Why?
Meningeal Neoplasms1202112160.450 Why?
Rectal Neoplasms1202111210.440 Why?
Proportional Hazards Models42021124560.410 Why?
Medical Oncology2202121180.390 Why?
Neoplasm Recurrence, Local5201788960.370 Why?
Randomized Controlled Trials as Topic4202195960.360 Why?
Information Dissemination3202110970.320 Why?
Salvage Therapy1201413040.310 Why?
Immunotherapy3202240950.300 Why?
Antineoplastic Agents32021136260.240 Why?
Models, Biological1202098090.230 Why?
Radiosurgery2202213490.220 Why?
Dacarbazine220225880.210 Why?
Pandemics1202173110.200 Why?
Survival Analysis62021104990.200 Why?
Medical Futility120221280.200 Why?
Melanoma1201852500.190 Why?
Humans3620227157770.180 Why?
Drug Resistance, Neoplasm1201451980.180 Why?
Drugs, Investigational120212340.170 Why?
Prostatic Neoplasms12021106050.170 Why?
Combined Modality Therapy3202088900.160 Why?
Clinical Trials as Topic4202279600.160 Why?
Standard of Care120215220.160 Why?
SEER Program1202215720.150 Why?
Hospitalization1201597450.140 Why?
Comparative Effectiveness Research120216890.140 Why?
Gene Dosage1202012700.140 Why?
Retrospective Studies122022724430.140 Why?
Tumor Burden3201819000.130 Why?
Lomustine12014670.130 Why?
Carmustine120141430.130 Why?
Neoplasms22021205280.130 Why?
Kaplan-Meier Estimate3202167220.130 Why?
Breast Neoplasms12021200620.120 Why?
Disease Progression52018132150.120 Why?
Infection Control120219550.120 Why?
Antineoplastic Combined Chemotherapy Protocols12014112360.120 Why?
Treatment Outcome82021620040.120 Why?
Magnetic Resonance Imaging72022344300.110 Why?
Carcinoma, Non-Small-Cell Lung2202149120.110 Why?
Astrocytoma120157920.100 Why?
Sarcoma1202218780.100 Why?
Female1520223772040.100 Why?
Aged, 80 and over62020583230.100 Why?
Aged920201624480.090 Why?
Middle Aged1220202146390.090 Why?
Patient Selection2202142930.090 Why?
Male1520213503240.090 Why?
Prognosis52022290050.090 Why?
Young Adult82018562260.090 Why?
Patient Participation1201814750.090 Why?
Risk1202198010.080 Why?
Adult1120222122660.080 Why?
Decision Making2202138460.080 Why?
Radiology1202119490.080 Why?
Computational Biology1202035710.080 Why?
Lung Neoplasms22021125390.070 Why?
Molecular Targeted Therapy1201828240.070 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors1202131490.070 Why?
Diffusion Magnetic Resonance Imaging2201626900.070 Why?
Survival Rate32017132060.070 Why?
Electronic Health Records1202242790.070 Why?
Neoplasm Proteins1201837410.070 Why?
Cues120108490.070 Why?
Head and Neck Neoplasms1201827190.060 Why?
Photic Stimulation1201020140.060 Why?
Algorithms22022137580.060 Why?
Reaction Time1201021110.060 Why?
Carcinoma, Squamous Cell1201839940.060 Why?
Mutation32022292910.050 Why?
Incidence22020207310.050 Why?
Students1201015630.050 Why?
Memory1201021430.050 Why?
Ribonuclease III120222750.050 Why?
Disease-Free Survival3201670150.050 Why?
Neoplasm Staging12014111450.050 Why?
DEAD-box RNA Helicases120223570.040 Why?
Risk Assessment12021234640.040 Why?
Pathology, Molecular120223480.040 Why?
Random Allocation1202224450.040 Why?
Necrosis1202016450.040 Why?
Probability1202224870.040 Why?
Follow-Up Studies22017393000.040 Why?
United States12022679050.030 Why?
Substance-Related Disorders1201041830.030 Why?
Retreatment120156230.030 Why?
Phantoms, Imaging1202224180.030 Why?
Clinical Trials, Phase II as Topic120156290.030 Why?
Immune Tolerance1202223130.030 Why?
Radiation Dosage1202120410.030 Why?
Area Under Curve1201516870.030 Why?
Echo-Planar Imaging120146750.020 Why?
Lymphatic Metastasis1201729680.020 Why?
High-Throughput Nucleotide Sequencing1202236890.020 Why?
Observer Variation1201526760.020 Why?
Risk Factors12015708660.020 Why?
ROC Curve1201535240.020 Why?
Neoplasm Metastasis1201850740.020 Why?
Marijuana Smoking120102520.020 Why?
Databases, Factual1202178950.020 Why?
Prospective Studies22021513150.020 Why?
Contrast Media1201752760.020 Why?
Image Interpretation, Computer-Assisted1201634130.010 Why?
Image Processing, Computer-Assisted1201790040.010 Why?
Time Factors12021408750.010 Why?
Predictive Value of Tests12014151990.010 Why?
Alcohol Drinking1201038990.010 Why?
Brain12022252060.010 Why?
Child12022744680.010 Why?
Rahman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (125)
Explore
_
Co-Authors (67)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.